HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup

STAT+: Trump administration revises rebate pilot for 340B drug discount program, angering hospitals

The Trump administration is revising its rebate pilot for the 340B drug discount program, angering hospitals.

By STAT News · Jul 31, 2026 · via STAT News
STAT+: Trump administration revises rebate pilot for 340B drug discount program, angering hospitals

Image: STAT News

This is an aggregated industry headline. Read the full story at STAT News

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Amylyx's patient education website aims to empower patients to navigate post-bariatric hypoglycemia (PBH), a r…
Aug 1, 2026
The WeekFierceBiotech ↗
A phase 3 trial of Novo Nordisk's ziltivekimab has missed its primary endpoint, denting the prospects of a mol…
Aug 1, 2026
Psychedelics, peptides and GLP-1s: the signals behind FiercePharma’s weekly watchlist
The WeekBriefing
FiercePharma’s “The Top Line” highlighted three pressure points this week: M&A in psychedelics, peptide re…
Aug 1, 2026